MIMS® Retrospective Chart Review

NCT06614218 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-01-10

No results posted yet for this study

Summary

This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.

Conditions

Interventions

DEVICE

Minimally Invasive Micro Sclerostomy

The MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the eye.

Sponsors & Collaborators

  • Sanoculis Ltd

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-01-01
Completion
2026-01-01

Countries

  • Armenia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614218 on ClinicalTrials.gov